Impact of biologics on growth in children with juvenile idiopathic arthritis

被引：0
|
作者：
F Uettwiller
G Pinto
M Polak
P Quartier
机构：
[1] CHU Clocheville,Unité de Spécialités Pédiatriques
[2] Necker Enfants Malades,Endocrinologie Pédiatrique
[3] d'Hématologie et de Rhumatologie Pédiatriques,Unité d'Immunologie
[4] Necker Enfants Malades,undefined
来源：
Pediatric Rheumatology | / 9卷 / Suppl 1期
关键词：
Growth Hormone; Juvenile Idiopathic Arthritis; Standard Deviation; Disease Onset; Biological Agent;
D O I：
10.1186/1546-0096-9-S1-P139
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] THE COST OF TREATING JUVENILE IDIOPATHIC ARTHRITIS IN THE ERA OF BIOLOGICS
    Gidman, Wendy K.
    Davies, Linda
    Carrasco, Roberto
    Hyrich, Kimme
    Thomson, Wendy
    Symmons, Deborah
    RHEUMATOLOGY, 2015, 54 : 5 - 6
  • [22] Dosing of Biologics in Juvenile Idiopathic Arthritis: Is the Sky the Limit?
    Prince, Femke H. M.
    Solomon, Daniel H.
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (10) : 1643 - 1645
  • [23] Biologics for treatment of juvenile idiopathic arthritis - Update 2007
    Horneff, G.
    AKTUELLE RHEUMATOLOGIE, 2007, 32 (03) : 128 - 135
  • [24] Current and emerging biologics for the treatment of juvenile idiopathic arthritis
    Cimaz, Rolando
    Maioli, Gabriella
    Calabrese, Giulia
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (07) : 725 - 740
  • [25] The necessity, efficacy and safety of biologics in juvenile idiopathic arthritis
    Cakan, Mustafa
    Ayaz, Nuray Aktay
    Karadag, Serife Gul
    Tanatar, Ayse
    NORTHERN CLINICS OF ISTANBUL, 2020, 7 (02) : 118 - 123
  • [26] USE OF NON-ETANERCEPT BIOLOGICS IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE BIOLOGICS FOR CHILDREN WITH RHEUMATIC DISEASES STUDY
    Kearsley-Fleet, Lianne
    Baildam, Eileen
    Beresford, Michael
    Davies, Rebecca
    Foster, Helen E.
    Mowbray, Katy
    Southwood, Taunton R.
    Thomson, Wendy
    Hyrich, Kimme L.
    RHEUMATOLOGY, 2014, 53 : 169 - 170
  • [27] Use of Non-Etanercept Biologics in Children with Juvenile Idiopathic Arthritis: Results From the Biologics for Children with Rheumatic Diseases Study
    Kearsley-Fleet, Lianne
    Baildam, Eileen
    Beresford, Michael
    Davies, Rebecca
    Foster, Helen E.
    Mowbray, Katy
    Southwood, Taunton R.
    Thomson, Wendy
    Hyrich, Kimme L.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S491 - S492
  • [28] USE OF NON-ETANERCEPT BIOLOGICS IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE BIOLOGICS FOR CHILDREN WITH RHEUMATIC DISEASES STUDY
    Kearsley-Fleet, Lianne
    Baildam, Eileen
    Beresford, Michael W.
    Davies, Rebecca
    Foster, Helen E.
    Mowbray, Katy
    Southwood, Taunton R.
    Thomson, Wendy
    Hyrich, Kimme L.
    RHEUMATOLOGY, 2013, 52 : 118 - 119
  • [29] Pharmacovigilance of Biologics for Systemic Juvenile Idiopathic Arthritis Patients By the German Biologics Registry
    Horneff, Gerd
    Ganser, Gerd
    Hospach, Toni
    Foeldvari, Ivan
    Borte, Michael
    Weller-Heinemann, Frank
    Minden, Kirsten
    Klein, Ariane
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [30] Effects of Growth Hormone Treatment on Growth in Children with Juvenile Idiopathic Arthritis
    Simon, D.
    Bechtold, S.
    HORMONE RESEARCH, 2009, 72 : 55 - 59
12345